Related Experiment Video
Updated: May 8, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Clinical spectrum in CADASIL family with a new mutation
Tomas Peisker1, Libor Musil, Martin Hrebicek
1Department of Neurology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Insights
A new NOTCH3 mutation (p.G296C) in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) causes varied symptoms, including stroke and migraine. Vascular changes were observed in all carriers, even asymptomatic ones.
Area of Science:
- Genetics
- Neurology
- Vascular Biology
Background:
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) diagnosis is challenging due to variable clinical presentations.
- The type of NOTCH3 mutation and other vascular risk factors contribute to this presentation variability.
Purpose of the Study:
- To investigate the clinical spectrum associated with a novel NOTCH3 mutation (p.G296C) in a CADASIL family.
- To determine the diagnostic utility of comprehensive clinical and genetic evaluations for novel CADASIL mutations.
Main Methods:
- Genetic testing was performed on six family members.
- Clinical, neuropsychological, cerebral MRI, Doppler sonography, fundoscopic examination, and fluorescent angiography were conducted.
- A novel NOTCH3 mutation on exon 6 (p.G296C) was identified.
Main Results:
- The CADASIL mutation was detected in four individuals, with three exhibiting symptoms.
- Symptomatic individuals presented with stroke and migraine.
- Vascular changes in cerebral and/or retinal arteries were present in all mutation carriers, including one asymptomatic individual.
Conclusions:
- The novel NOTCH3 p.G296C mutation is associated with CADASIL.
- Heterogeneous clinical presentations can occur even with the same mutation.
- Vascular changes are a consistent finding in carriers, regardless of clinical manifestation.
Background:
Clinical presentation of CADASIL patients is variable due to the impact of other vascular risk factors and the type of a NOTCH3 mutation. This variability may impede the diagnosis of the disease.
Subjects And Methods:
We report a comprehensive evaluation of several individuals in the CADASIL family whose member was identified to have the new mutation of NOTCH3 receptor on exon 6 (p. G296C). We performed genetic testing, clinical and neuropsychological examination, cerebral MRI, Doppler sonography of cerebral arteries, fundoscopic examination and fluorescent angiography in six family members to determine the corresponding clinical spectrum associated with the new mutation.
Results And Conclusion:
The CADASIL mutation was detected in four individuals. Three of them were symptomatic, two having a history of stroke and one suffering from migraine. Although individuals had heterogeneous findings, the common feature included vascular changes that were present on cerebral and/or retinal arteries in all the mutation carriers even in one subject without clinical manifestation of the disease.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Huntington Disease l: Introduction
Mutations
The Ras Gene
Ras is a superfamily...
Incomplete Dominance

